SBIR-STTR Award

A Computer Model of Renal Physiology for Use as a FDA Medical Device Development Tool
Award last edited on: 6/4/2019

Sponsored Program
SBIR
Awarding Agency
NIH : FDA
Total Award Amount
$572,902
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
William Andrew Pruett

Company Information

HC Simulation LLC

1577 Barnes Road
Canton, MS 39046
   (601) 594-2230
   N/A
   justphysiology.com
Location: Single
Congr. District: 02
County: Madison

Phase I

Contract Number: 1R43FD005669-01
Start Date: 9/15/2016    Completed: 3/31/2017
Phase I year
2016
Phase I Amount
$131,863
The purpose of this proposal is to develop a validated physiological model of the cardio- renal axis for submission to the FDA Medical Device Development Tool pilot program. The model will be used to aid in the development and regulation of devices intended to treat hypertension. Examples include medical devices for renal nerve ablation, electrical stimulation of the carotid baroreceptor or creation of an A-V Fistula. Given that 12-15% of US patients with uncontrolled hypertension even with the use of 4 or more drugs at a price tag of $11-$17 billion, the importance of a tool that streamlines the time for design, testing, and regulation of a non- pharmacological device is clear. The multifactorial nature of hypertension complicates its treatment, and no device intervention is guaranteed to successfully treat each patient. Our physiological model is a powerful tool for understanding interpatient variability and confirming the correctness of a device's context of use. In Phase I, we will demonstrate a validated and documented renal model, using HumMod, our existing model of human physiology as the basis for the new model. The aims of this study include: 1) the transfer of the model from a proprietary simulation environment into a more powerful, validated framework, 2) documentation of the model by linking a bibliographic database with a wiki, and 3) a validation suite to ensure that the model functions correctly. The model will be implemented in Modelica, a multi-domain modeling language for modeling of complex system. In Phase II, we will use the workflows developed in Phase I to create, document, and validate the cardiovascular part of the axis, including neural reflex arcs and the relevant endocrine systems.

Public Health Relevance Statement:


Public Health Relevance:
This proposal will fund the development, documentation, and validation of a mathematical model that will aid device manufacturers and the FDA to streamline the current regulatory process. This will reduce the cost and time associated with bringing new devices to market while adding another layer of protection for consumers.

Project Terms:
No Project Terms available.

Phase II

Contract Number: 2R44FD005669-02
Start Date: 9/15/2016    Completed: 8/31/2019
Phase II year
2018
Phase II Amount
$441,039
The purpose of this proposal is to develop a validated physiological model of the human physiology, especially the cardio-renal axis, for submission to the FDA Medical Device Development Tool pilot program. The model will be used to aid in the development and regulation of medical devices designed to treat hypertension. Examples include devices for renal nerve ablation, electrical stimulation of the carotid baroreceptors and creation of an A-V Fistula. Given that 12-15% of US patients with resistant hypertension on 4 or more drugs, at a price tag of $11-$17 billion, the importance of a tool that streamlines the time for design, testing, and regulation of a non-pharmacological device is clear. The multifactorial nature of hypertension complicates its treatment, and no device intervention is guaranteed to successfully treat each patient. Our physiological model is a powerful tool for understanding the impact of interpatient variability on antihypertensive therapies and confirming the correctness of using a specific device for blood pressure control. In Phase II, we will demonstrate a validated and documented model, extending HumMod, our existing model of human physiology, to include more intracellular signaling and adaptation, as well as a multilevel, detailed circulation. The aims of this study include: 1) the complete transfer of the model from a proprietary simulation environment into Modelica, a multi- domain language for modeling of complex systems, 2) documentation of model evidence and structure in a searchable repository, and 3) a verification suite to ensure that the model functions correctly.

Thesaurus Terms: